Collaboration Details

Print  Close

Title of Collaborative Activity:

Proteomics (NCI/FDA Memorandum of Understanding)

Description of Collaborative Activity:

The purpose of this MOU is to create a framework to foster scientific and programmatic collaborations. The collaborations envisioned by this MOU involve proteomics science and technology applications such as instrument/technology validation, informatics, biological sample preparation, diagnostics, and discovery and validation of biomarkers for cancer development, therapeutics, and response. This MOU sets forth the basic principles under which the agencies intend to work together to foster partnership in: research and education; the exchange of ideas, information, and data; the development and use of proteomics technologies that may be used by the NCI and other sponsors in clinical applications.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: